NASDAQ:VERV - Nasdaq - US92539P1012 - Common Stock - Currency: USD
Taking everything into account, VERV scores 3 out of 10 in our fundamental rating. VERV was compared to 551 industry peers in the Biotechnology industry. VERV has a great financial health rating, but its profitability evaluates not so good. VERV is valued expensive and it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -29.47% | ||
ROE | -38.23% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 2.34 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 9.84 | ||
Quick Ratio | 9.84 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
11.13
+0.03 (+0.27%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 16.64 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.1 | ||
P/tB | 2.1 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -29.47% | ||
ROE | -38.23% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 66.21% | ||
Cap/Sales | 7.59% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 9.84 | ||
Quick Ratio | 9.84 | ||
Altman-Z | 2.34 |